OppenheimerFunds’s IDENIX PHARMACEUTICALS INC IDIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
Sell
-14,127
Closed -$340K 1006
2014
Q2
$340K Buy
+14,127
New +$147K ﹤0.01% 894

OppenheimerFunds's IDIX Position: Q3 2014 in Review

OppenheimerFunds sold out of IDENIX PHARMACEUTICALS INC (IDIX) in Q3 2014, closing a stake of 14,127 shares — an estimated $340K sold.

OppenheimerFunds first reported a position in IDIX in Q2 2014 and held it in 1 quarter. The position peaked at $340K in Q2 2014. 0 funds tracked by Wall St. Rank hold IDIX as of Q3 2014.

  • OppenheimerFunds reported no remaining IDENIX PHARMACEUTICALS INC position as of Q3 2014 after selling out during the quarter.
  • OppenheimerFunds sold 14,127 IDENIX PHARMACEUTICALS INC shares in Q3 2014, an estimated $340K.
  • OppenheimerFunds first reported a position in IDENIX PHARMACEUTICALS INC in Q2 2014 and held it in 1 quarter.
  • OppenheimerFunds's IDENIX PHARMACEUTICALS INC position peaked at $340K in Q2 2014.
  • 0 funds tracked by Wall St. Rank held IDENIX PHARMACEUTICALS INC as of Q3 2014.

Based on OppenheimerFunds's 13F filing for Q3 2014, filed 13 Nov 2014.